• We have the know-how to quickly and firmly proceed from discovery of new materials, basic research, animal and human testing and approval to the Ministry of Food and Drug Safety through R&D personnel composed of top experts in the biotechnology field, and we are doing our best as a leader in the development of bio-healthcure products.

• We have established several cooperative networks and are working closely with domestic and foreign universities and research institutes, pharmaceutical companies, and large hospitals. And we are preparing for global advancement through overseas licensing of natural products currently under development in Europe, the United States, China and Southeast Asia.
• Our technological prowess has received high ratings from various technology evaluation organizations, including the Korea Technology Finance Corporation. In 2017, we were selected for a large-scale national project hosted by the Ministry of Agriculture, Food and Rural Affairs and are conducting research on the development of high value-added products.
• In particular, our shingles treatment has been recognized for its huge potential in Europe's top biogroup and is currently in the process of international co-commercialization.

• GENENCELL is conducting in-depth research in all fields of life science as well as natural products. We want to contribute to global health cure by providing reliable products to people around the world through research and development using advanced techniques.

CEO